NQO1 and cancer: β-lap’s therapeutic efficacy mainly stems from β-lap-induced futile redox cycling in NQO1+ cancer cells, producing oxidative DNA lesions and consequent cell death, while normal tissues are spared by low NQO1 expression [7, 8].